TrialThe European journal of health economics : HEPAC : health economics in prevention and care2014

Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.

Alvaro Hidalgo-Vega et al.PubMed ↗Publisher ↗

No numbers read from the abstract.